Recruiting Ankylosing Spondylitis Studies in Burlington
About Ankylosing Spondylitis Clinical Trials in Burlington
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Burlington, VT. These studies are seeking a combined 2,000,100 participants. Research is being sponsored by Helix, Inc, Boston Scientific Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Burlington — FAQ
Are there ankylosing spondylitis clinical trials in Burlington?
Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Burlington, VT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Burlington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Burlington research site will contact you about next steps.
Are clinical trials in Burlington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Burlington studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 2 active trials in Burlington are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated July 17, 2026 from ClinicalTrials.gov